Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.210
+0.005 (0.41%)
Jul 27, 2026, 4:00 PM EDT - Market closed
Metagenomi Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 25.31 | 41.72 | 27.39 | 140.6 | 184.44 | 39.3 |
Short-Term Investments | 114.86 | 119.08 | 220.92 | 130.58 | 177.69 | 68.86 |
Cash & Short-Term Investments | 140.16 | 160.8 | 248.31 | 271.18 | 362.13 | 108.15 |
Cash Growth | -37.97% | -35.24% | -8.43% | -25.11% | 234.83% | - |
Accounts Receivable | - | 0.31 | 1.26 | 2.45 | - | - |
Other Receivables | - | - | - | - | 1.27 | - |
Total Trade Receivables | - | 0.31 | 1.26 | 2.45 | 1.27 | - |
Other Current Assets | 4.4 | 4.43 | 8.4 | 4.64 | 3.49 | 0.76 |
Total Current Assets | 144.56 | 165.54 | 257.96 | 278.27 | 366.9 | 108.92 |
Net Property, Plant & Equipment | 44.92 | 47.38 | 57.66 | 65.15 | 33.26 | 21.89 |
Long-Term Investments | 2.15 | 2.15 | 3.45 | 10.68 | 7.81 | 6.42 |
Other Long-Term Assets | 5.32 | 6.03 | 5.54 | 10.74 | 6.52 | 4.77 |
Total Assets | 196.95 | 221.1 | 324.6 | 364.84 | 414.49 | 141.99 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.4 | 1.49 | 0.53 | 1.79 | 2.01 | 1.35 |
Accrued Expenses | 4.69 | 6.72 | 8.42 | 11.47 | 8.79 | 3.53 |
Current Portion of Leases | 6.11 | 6.03 | 5.59 | 3.43 | 1.52 | 0.69 |
Unearned Revenue | 9.31 | 8.7 | 22.76 | 48.91 | 34.69 | 19.6 |
Other Current Liabilities | - | - | - | 3.27 | 1.54 | - |
Total Current Liabilities | 22.5 | 22.93 | 37.31 | 68.86 | 48.54 | 25.17 |
Long-Term Debt | - | - | - | - | - | 30.28 |
Long-Term Leases | 33.08 | 34.63 | 40.19 | 44.8 | 17.06 | 17.97 |
Other Long-Term Liabilities | 3.59 | 4.94 | 12.25 | 36.01 | 77.22 | 24.63 |
Total Long-Term Liabilities | 36.67 | 39.57 | 52.43 | 80.81 | 94.27 | 72.87 |
Total Liabilities | 59.17 | 62.51 | 89.74 | 149.67 | 142.81 | 98.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | 0.03 | 0.03 |
Additional Paid-in Capital | 471.75 | 469.2 | 457.15 | 9.46 | 2.51 | 0.55 |
Accumulated Other Comprehensive Income | -0.04 | 0.26 | 0.71 | -0.1 | -0.27 | -0.02 |
Retained Earnings | -333.93 | -310.87 | -223 | -144.94 | -76.69 | -33.1 |
Total Common Shareholders' Equity | 137.79 | 158.6 | 234.86 | -135.58 | -74.43 | -32.54 |
Minority Interest | - | - | - | 350.76 | 346.1 | 76.5 |
Shareholders' Equity | 137.79 | 158.6 | 234.86 | 215.17 | 271.68 | 43.95 |
Total Liabilities & Equity | 196.95 | 221.1 | 324.6 | 364.84 | 414.49 | 141.99 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 39.19 | 40.66 | 45.78 | 48.23 | 18.57 | 48.93 |
Net Cash (Debt) | 100.98 | 120.14 | 202.53 | 222.95 | 343.56 | 59.23 |
Net Cash Growth | -44.38% | -40.68% | -9.16% | -35.10% | 480.08% | - |
Net Cash Per Share | 2.70 | 3.23 | 6.13 | 65.49 | 101.06 | 17.40 |
Book Value | 137.79 | 158.6 | 234.86 | -135.58 | -74.43 | -32.54 |
Book Value Per Share | 3.69 | 4.26 | 7.11 | -39.82 | -21.89 | -9.56 |
Tangible Book Value | 137.79 | 158.6 | 234.86 | -135.58 | -74.43 | -32.54 |
Tangible Book Value Per Share | 3.69 | 4.26 | 7.11 | -39.82 | -21.89 | -9.56 |